
TerrAscend Corp.
TerrAscend Corp. (TRSSF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TRSSF · as of Jun 8, 2026
Key Statistics
Explore TerrAscend Corp. Data
trssf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 33.3%
The TRSSF analyst consensus is Hold, based on ratings from 3 Wall Street analysts over the past 3 months. The average 12-month price target is $2.93, representing +70.35% upside from the current price of $1.72.
Competitors & Peers
trssf competitorsStock Performance
Full HistoryAbout TerrAscend Corp.
TerrAscend Corp. operates as a vertically integrated cannabis company, engaged in the cultivation, processing, and sale of both medical and adult-use cannabis across Canada and the United States. Beyo…
what is terrascend corp. · trssf stock overview · terrascend corp. company profile · who is terrascend corp. ceo · trssf OTC · terrascend corp. headquarters · terrascend corp. business segments
About Stock Overview & Key Data
TerrAscend Corp. (TRSSF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Nov 17, 2017. As of the latest trading session, TRSSF stock price is $1.72, with a market capitalization of $601.9M. The stock has returned -26.50% over the past 12 months and +54.84% year-to-date.
According to 3 Wall Street analysts, the consensus rating for TerrAscend Corp. stock is Hold, with an average 12-month price target of $2.93. In fiscal year 2025, TerrAscend Corp. reported revenue of $260.6M and net income of -$81.3M. For detailed data — including TerrAscend Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, TerrAscend Corp. (TRSSF) stock price is $1.72. The stock is traded on OTC under the ticker symbol TRSSF. The 52-week range is $1.00 – $3.09.